Home Cart Sign in  
Chemical Structure| 151358-47-3 Chemical Structure| 151358-47-3

Structure of DIM-C-pPhOH
CAS No.: 151358-47-3

Chemical Structure| 151358-47-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DIM-C-pPhOH is Nur77 antagonist which can induce conformational change.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DIM-C-pPhOH

CAS No. :151358-47-3
Formula : C23H18N2O
M.W : 338.40
SMILES Code : OC1=CC=C(C(C2=CNC3=C2C=CC=C3)C4=CNC5=C4C=CC=C5)C=C1
MDL No. :MFCD03723253
InChI Key :QCPDFNWJBQMXLI-UHFFFAOYSA-N
Pubchem ID :2940609

Safety of DIM-C-pPhOH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
ACHN cells 0-20 μM 24 hours Inhibited cell proliferation, IC50 value was 13.6 μM PMC4452731
Panc-1 cells 25 μM 24 hours Induces ER stress-mediated apoptosis by increasing ROS production PMC4407472
MDA-MB-231 cells 20 μM 24 hours DIM-C-pPhOH induced the expression of SERPINB5, GADD45α, and p21 proteins. PMC6681651
786-O cells 0-20 μM 24 hours Inhibited cell proliferation, IC50 value was 13.0 μM PMC4452731
A549 cells 10 μM and 20 μM 24 hours Caused G0/G1 phase arrest in A549 cells, resulting in 74.46±0.66% and 81.66±0.22% of cells accumulating in G1 phase at 10 μM and 20 μM concentrations, respectively. PMC3838903
MCF-7 breast cancer cells 15 or 20 μM 24 hours To investigate the effect of DIM-C-pPhOH on MCF-7 cell migration, results showed that DIM-C-pPhOH significantly inhibited cell migration. PMC4836213
MDA-MB-231 breast cancer cells 15 or 20 μM 24 hours To investigate the effect of DIM-C-pPhOH on MDA-MB-231 cell migration, results showed that DIM-C-pPhOH significantly inhibited cell migration. PMC4836213
SKBR3 breast cancer cells 15 or 20 μM 24 hours To investigate the effect of DIM-C-pPhOH on SKBR3 cell migration, results showed that DIM-C-pPhOH significantly inhibited cell migration. PMC4836213
Rh30 cells 20 μM 24 hours Induced ROS accumulation and IL-24 expression, inhibited cell proliferation and migration, and induced apoptosis PMC6825581
RD cells 20 μM 24 hours Induced ROS accumulation and IL-24 expression, inhibited cell proliferation and migration, and induced apoptosis PMC6825581
SKBR3 cells 20 μM 24 hours RNAseq analysis showed that compared to control (DMSO) cells, DIM-C-pPhOH treatment altered the expression of 1823 genes. PMC6681651
Colon cancer cells (RKO, SW480) 15 and 20 μM 24 hours Decreased β1-integrin expression, inhibited cell migration and adhesion PMC5546981
Pancreatic cancer cells (Panc1, L3.6pL, MiaPaCa2) 15 and 20 μM 24 hours Decreased β1-integrin expression, inhibited cell migration and adhesion PMC5546981
H1299 cells 20 μM 3 days DIM-C-pPhOH inhibited H1299 cell proliferation and induced apoptosis by inactivating the TR3/p300/Sp1 complex. PMC3299891
H460 cells 20 μM 3 days DIM-C-pPhOH inhibited H460 cell proliferation and mTORC1 signaling through activation of the p53/sestrin2/AMPK α axis. PMC3299891
A549 cells 20 μM 3 days DIM-C-pPhOH inhibited A549 cell proliferation and mTORC1 signaling through activation of the p53/sestrin2/AMPK α axis. PMC3299891
L3.6pl cells 15.61 μM (IC50) 48 hours Inhibited cell proliferation and induced apoptosis, accompanied by decreased Bcl-2 and survivin expression, and increased caspase-3 and PARP cleavage PMC2988472
MiaPaCa-2 cells 13.87 μM (IC50) 48 hours Inhibited cell proliferation and induced apoptosis, accompanied by decreased Bcl-2 and survivin expression, and increased caspase-3 and PARP cleavage PMC2988472
Panc1 cells 11.35 μM (IC50) 48 hours Inhibited cell proliferation and induced apoptosis, accompanied by decreased Bcl-2 and survivin expression, and increased caspase-3 and PARP cleavage PMC2988472
A549 cells 10 μM and 20 μM 48 hours Induced apoptosis in A549 cells, resulting in 26±1.05% and 25.5±2.40% apoptosis at 10 μM and 20 μM concentrations, respectively. PMC3838903

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice (NCr-nu/nu) Orthotopic model of pancreatic cancer Oral gavage 30 mg/kg Once daily for 4 weeks Inhibited tumor growth and induced apoptosis, accompanied by decreased Bcl-2 and survivin expression, and increased caspase-3 and PARP cleavage PMC2988472
Nu/Nu mice A549 cell lung metastasis model Inhalation 5 mg/ml Alternate days for 4 weeks Significantly inhibited lung tumor growth, reduced tumor nodules, and decreased VEGF and CD31 expression, demonstrating anti-angiogenic and anti-metastatic activities. PMC3838903
Nude mice Orthotopic and metastatic lung cancer models Oral gavage 30 mg/kg 3 times per week for 4 weeks DIM-C-pPhOH significantly inhibited tumor growth in orthotopic and metastatic lung cancer models and induced tumor cell apoptosis. PMC3299891
Athymic nude mice ACHN cell xenograft model Oral gavage 30 mg/kg Once daily for 50 days Significantly inhibited tumor growth PMC4452731

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.78mL

2.96mL

1.48mL

29.55mL

5.91mL

2.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories